Heidelberg Pharma GmbH is a company providing pre-clinical drug discovery and development services. Services include explorative pharmacology in the field of cancer, autoimmunity and inflammation, hand-in-hand with bioanalytical methods. Our performance for our clients is characterized by a high degree of flexibility, rapid turn-around and consistent high quality. Heidelberg Pharma's own R&D flagship is its proprietary 2nd generation ADC technology for more effective anti-cancer drugs.
News & Events: May 2013
Heidelberg Pharma has relaunched its website. The site's fresh design and renewed content will provide visitors with a clear understanding of the pre-clincal services offered by Heidelberg Pharma. The new website includes more in-depth information about Heidelberg Pharma's ADC technology.